Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
COVID-19
MedTech
Quest predicts 80% drop in 2023 COVID-19 test revenues
Quest's 2022 COVID-19 revenues were barely half the size of the previous year’s—and it's expecting 2023’s haul to shrink to an even smaller fraction.
Andrea Park
Feb 6, 2023 10:33am
BD ups outlook amid stagnant base business, COVID testing crash
Feb 2, 2023 1:06pm
With COVID windfalls fading, Hologic eyes more tuck-in deals
Feb 2, 2023 11:40am
Siemens' diagnostics division falls 24% in COVID-light Q1
Feb 2, 2023 11:14am
Thermo Fisher revenues jump 15% in 2022
Feb 1, 2023 11:19am
CureVac posts mRNA flu, COVID-19 vaccine data in older adults
Jan 30, 2023 9:35am
More News
Altamira stakes for-sale sign again after asset deal crumbles
Jan 27, 2023 11:24am
Abbott ekes out 1.3% growth in 2022 amid COVID testing drop-off
Jan 25, 2023 12:13pm
BioNTech not giving up on fighting symptomatic COVID
Jan 10, 2023 4:18pm
JPM23: What testmakers like Freenome are taking away from COVID
Jan 10, 2023 10:10am
See more